SoftBank Group plans to create and list AI/robotics firm Roze in the United States as early as 2026.
The company targets a valuation of up to $100 billion for Roze, though the exact stake SoftBank will sell remains undecided.
SoftBank still holds about 90% of Arm Holdings and this listing follows Masayoshi Son’s aggressive AI push, including OpenAI spending.
The overseas IPO faces risk amid US‑Iran tensions, while US markets anticipate other mega‑IPOs like SpaceX, Anthropic and OpenAI.